RT @NephJC: T0k: Outside the hospital now, in post-SPRINT era, lower BP=better. However, this meta-analysis including elderly patients (par…
T0k: Post-SPRINT era, lower BP =better (Outside hospital setting) 📍However, this meta-analysis including elderly patients (part of them from SENIOR-SPRINT), raised more concerns 📍Tenacious docs say individualizing the treatment is the key #NephJC h
RT @NephJC: T0k: Outside the hospital now, in post-SPRINT era, lower BP=better. However, this meta-analysis including elderly patients (par…
RT @NephJC: T0k: Outside the hospital now, in post-SPRINT era, lower BP=better. However, this meta-analysis including elderly patients (par…
RT @NephJC: T0k: Outside the hospital now, in post-SPRINT era, lower BP=better. However, this meta-analysis including elderly patients (par…
RT @NephJC: T0k: Outside the hospital now, in post-SPRINT era, lower BP=better. However, this meta-analysis including elderly patients (par…
T0k: Outside the hospital now, in post-SPRINT era, lower BP=better. However, this meta-analysis including elderly patients (part of them from SENIOR-SPRINT), raised more concerns to which tenacious docs say individualizing the treatment is the key #NephJC
STEP is a landmark trial. Great to see validation of our work where we found a target of SBP <140 mm Hg in individuals >=65y. https://t.co/PSHoj5eRUs STEP trial -> 110-130 mm Hg may be ideal. Need 2 be careful about polypharmacy & effects of
Rigorous Blood Glucose (BG) and Blood Pressure (BP) control prevented complications of diabetes. Systolic BP <120 mmHg decreased cardiovascular events and death. #Patient’s education #Lifestyle changes# Monitoring BG & BP# https://t.co/IeDuK7QSgL
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients @JACCJournals https://t.co/RcXoBgG3G3
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients. https://t.co/AyVDUExqgN
Intensive blood pressure lowering increases kidney failure risk in elderly OR "Out of the frying pan into the fire" https://t.co/W603nDJ3ad
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients. https://t.co/u3Dxxo7v5v
RT @sanoysalvoblog: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients https://t.co/sX2ovcX40b #PtSafety
RT @sanoysalvoblog: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients https://t.co/sX2ovcX40b #PtSafety
RT @sanoysalvoblog: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients https://t.co/sX2ovcX40b #PtSafety
RT @sanoysalvoblog: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients https://t.co/sX2ovcX40b #PtSafety
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients https://t.co/mOFeJuyXNh #PtSafety via sanoysalvoblog
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients https://t.co/sX2ovcX40b #PtSafety
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients — ScienceDirect https://t.co/G427gptJou
Debemos valorar riesgos y beneficios de control estricto de ta en adultos mayores. https://t.co/QN0p5nInVj https://t.co/LGmjmiLitx
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
Back at it again: Intensive BP lowering in older hypertensive patients? https://t.co/HzRDtpNXs1
New review of HTN Rx Tx targets: (!!) 48% of older adults in SPRINT had SERIOUS Adverse Event, (no dif between gps) https://t.co/gRA3A2ZuKX
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @DanielReyAldana: Resultados de un manejo intensivo de la #HTA en pacientes #ancianos https://t.co/i8pma5mQJR https://t.co/IFXXSxoO7z
New post in Dev. of Pharmacy Career Channel: https://t.co/JdzRSrpjRF https://t.co/ptX6ZNAFmD
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @hswapnil: Compare & contrast with @AnnalsofIM SR https://t.co/YIlhZqG4Gi from @DevanKansagara et al for @ACPinternists @aafp G/L https:…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
New meta-analysis shows that intensive BP control in older patients can decrease CV mortality and heart failure https://t.co/0A4w2Gmh5b
Compare & contrast with @AnnalsofIM SR https://t.co/YIlhZqG4Gi from @DevanKansagara et al for @ACPinternists @aafp G/L https://t.co/HoHyS5zHIp
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
Maybe not... https://t.co/6KATDFEfX2
Resultados de un manejo intensivo de la #HTA en pacientes #ancianos https://t.co/4I9eME8HHL https://t.co/IFXXSxoO7zagustinpazosl
RT @DanielReyAldana: Resultados de un manejo intensivo de la #HTA en pacientes #ancianos https://t.co/i8pma5mQJR https://t.co/IFXXSxoO7z
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
Resultados de un manejo intensivo de la #HTA en pacientes #ancianos https://t.co/i8pma5mQJR https://t.co/IFXXSxoO7z
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @ArdenBarry: New meta-analysis of intensive BP control in older patients with #hypertension: https://t.co/Cjzc1Lp7o1 @JACCJournals https…
RT @ArdenBarry: New meta-analysis of intensive BP control in older patients with #hypertension: https://t.co/Cjzc1Lp7o1 @JACCJournals https…
New meta-analysis of intensive BP control in older patients with #hypertension: https://t.co/Cjzc1Lp7o1 @JACCJournals https://t.co/5RAMZ4Ivb2
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @IlindelatorreMD: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients | JACC https://t.co/5FCIPqdW8w https://t.…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @rincondesisifo: (JACC) Seguridad y eficacia del control intensivo (PS <140 mm Hg) de la PA en ancianos https://t.co/CC0PhZCxa7 Rev Sist
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
Intensive BP lowering reduces MACE in older pts| v risk of renal failure, monitor those ACEI/ARBs. https://t.co/zXj1MvwwzD #rxtweetproject
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @IlindelatorreMD: Adultos mayores hipertensos: control intensivo PA (PA sistólica <140 mmHg) ↓mortalidad CV y fallo cardíaco. https://…
RT @IlindelatorreMD: Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients | JACC https://t.co/5FCIPqdW8w https://t.…
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients | JACC https://t.co/5FCIPqdW8w https://t.co/CTQYmNdWzu
RT @JACCJournals: Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https:…
RT @IlindelatorreMD: Adultos mayores hipertensos: control intensivo PA (PA sistólica <140 mmHg) ↓mortalidad CV y fallo cardíaco. https://…
Adultos mayores hipertensos: control intensivo PA (PA sistólica <140 mmHg) ↓mortalidad CV y fallo cardíaco. https://t.co/KhibNVzt32
Lower MACE but more renal failure? Is intensive BP control right for older patients? #JACC https://t.co/0Jf6sOsGfM https://t.co/UnidjedYpz
RT @JACCJournals: Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
Is lower BP better for older patients? New work looks at lower targets than JNC8 #JACC https://t.co/3GzxgFU6Df https://t.co/ICd7p7XDC4
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
Data on adverse events needed to fully assess this study of blood pressure control in older patients w/ hypertension -- and all others. https://t.co/XkabsZMNLM
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @IntraMednet: ¿Tratamiento intensivo de HTA en mayores 60 años? Riesgos/beneficios https://t.co/XAGMf1e0fI https://t.co/9kQSaYbS8n
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
RT @IntraMednet: ¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https…
¿Es prudente el tratamiento intensivo de la HTA en mayores de 60 años? Riesgos y beneficios. https://t.co/xsXjDJDuqX https://t.co/WfNtXNVT2I
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @hmkyale: Hard to put a lot of stock in medical study of Rx w/this in the conclusion: 'Data on adverse events were limited.' https://t.c…
RT @drjohnm: This line in conclusion (w slight edit) > When considering [anything] clinicians should carefully weigh benefits against pote…
This line in conclusion (w slight edit) > When considering [anything] clinicians should carefully weigh benefits against potential risks. https://t.co/qFGFIkzrPc